Fidelity Investments’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.6K Sell
2,308
-456
-16% -$337 ﹤0.01% 5068
2025
Q4
$1.97K Hold
2,764
﹤0.01% 5015
2025
Q3
$4.48K Hold
2,764
﹤0.01% 4808
2025
Q2
$1.69K Sell
2,764
-23,456
-89% -$11.9K ﹤0.01% 4878
2025
Q1
$14.9K Sell
26,220
-8,453
-24% -$8.34K ﹤0.01% 4344
2024
Q4
$49.6K Sell
34,673
-1,311,265
-97% -$2.94M ﹤0.01% 3854
2024
Q3
$2.6M Buy
1,345,938
+25,503
+2% +$72K ﹤0.01% 2323
2024
Q2
$4.09M Sell
1,320,435
-1,589,691
-55% -$6.56M ﹤0.01% 2139
2024
Q1
$15.2M Buy
2,910,126
+255,375
+10% +$1.22M ﹤0.01% 1750
2023
Q4
$8.6M Sell
2,654,751
-532,000
-17% -$1.15M ﹤0.01% 1895
2023
Q3
$8.13M Sell
3,186,751
-567,488
-15% -$2.38M ﹤0.01% 1891
2023
Q2
$22M Sell
3,754,239
-6,057
-0.2% -$35.2K ﹤0.01% 1602
2023
Q1
$10.7M Buy
3,760,296
+929,820
+33% +$2.61M ﹤0.01% 1848
2022
Q4
$5.69M Sell
2,830,476
-294,822
-9% -$720K ﹤0.01% 2079
2022
Q3
$9.06M Sell
3,125,298
-2,403,744
-43% -$11.2M ﹤0.01% 1934
2022
Q2
$31.1M Sell
5,529,042
-662,966
-11% -$5.36M ﹤0.01% 1470
2022
Q1
$72.9M Buy
6,192,008
+468,276
+8% +$5.67M 0.01% 1222
2021
Q4
$107M Buy
5,723,732
+620,255
+12% +$13.5M 0.01% 1076
2021
Q3
$102M Buy
+5,103,477
New +$110M 0.01% 1100

Other funds holding TNYA

Fidelity Investments's TNYA Position: Q1 2026 in Review

Fidelity Investments reduced its Tenaya Therapeutics (TNYA) stake by 16% in Q1 2026, selling an estimated $337 and leaving 2,308 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5068.

Fidelity Investments first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $107M in Q4 2021. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Fidelity Investments held 2,308 shares of Tenaya Therapeutics worth $1.6K as of Q1 2026.
  • Fidelity Investments sold 456 Tenaya Therapeutics shares in Q1 2026, an estimated $337.
  • Tenaya Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5068 holding.
  • Fidelity Investments first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Fidelity Investments's Tenaya Therapeutics position peaked at $107M in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.